Amgen announces new T-cell collaboration
admin 4th October 2017 Uncategorised 0Will team with CytomX Therapeutics on Probody T-cell engaging bispecific More: Amgen announces new T-cell collaboration Source: News
read moreWill team with CytomX Therapeutics on Probody T-cell engaging bispecific More: Amgen announces new T-cell collaboration Source: News
read moreTeva’s drug is most prescribed treatment for relapsing forms of MS in the US More: FDA approves Mylan's generic Copaxone Source: News
read moreHere is some other vaccine news of note for this week. More: News of Note—Dynavax and Hilleman Labs Source: fierce
read moreHoping to improve on the flu vaccine status quo, researchers in England are kicking off the world’s first large human trial of a “universal” influenza shot. More: Vaccitech 'universal' flu shot set for phase 2 study in U.K. Source: fierce
read moreThe world already has a super-successful pneumococcal conjugate vaccine in Pfizer’s Prevnar 13, but that isn’t stopping PnuVax from pushing ahead with its own program. As it works toward its goal of eventually licensing a vaccine and providing low-cost doses
read moreFrench police searched a plant today where Merck KGaA makes thyroid drug Levothyrox as consumer complaints have piled up over a formulation change the drugmaker made at the request of French regulators. More: French police visit Merck KGaA plant in
read more© 1994 - 2024 B.M. Pharmaceuticals